Cel AI (CLAI)

Sector:

Pharma and Biotech

 0.16p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.25
  • 52 Week Low: 0.14
  • Currency: UK Pounds
  • Shares Issued: 602.25m
  • Volume: 751,561
  • Market Cap: £0.93m

Latest Trades

Time Price Volume Value Buy/Sell Type
15:47 0.14p 99 £0 Sell O
15:44 0.16p 53,748 £88 Buy O
15:19 0.15p 74 £0 Sell O
14:58 0.15p 305,220 £443 Sell O
14:58 0.17p 1,923 £3 Buy O
14:55 0.14p 3,988 £6 Sell O
14:41 0.17p 2,929 £5 Buy O
14:23 0.15p 11,713 £17 Sell O
13:48 0.14p 128 £0 Sell O
13:13 0.14p 509 £1 Sell O
12:14 0.14p 41 £0 Sell O
10:04 0.14p 103 £0 Sell O
10:02 0.16p 305,220 £498 Buy O
10:01 0.14p 14 £0 Sell O
10:01 0.14p 7,231 £10 Sell O
08:55 0.17p 58,529 £100 Buy O
08:22 0.14p 92 £0 Sell O

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Cel AI Market Data

Currency UK Pounds
Share Price 0.16p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.25
52 Week Low 0.14
Volume 751,561
Shares Issued 602.25m
Market Cap £0.93m

Cel AI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
96.99% below the market average96.99% below the market average96.99% below the market average96.99% below the market average96.99% below the market average
96.3% below the sector average96.3% below the sector average96.3% below the sector average96.3% below the sector average96.3% below the sector average
Income Not Available
Growth
21.40% above the market average21.40% above the market average21.40% above the market average21.40% above the market average21.40% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average

Cel AI Dividends

No dividends found

Trades for 15-May-2024

Time Volume / Share Price
15:47 99 @ 0.14p
15:44 53,748 @ 0.16p
15:19 74 @ 0.15p
14:58 305,220 @ 0.15p
14:58 1,923 @ 0.17p

Cel AI Key Personnel

CFO Bruna Nikolla

Top of Page